ALX Oncology Holdings Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
BCAB
BioAtla, Inc. |
$0.60 | $73.14 M | -0.61 | 65 | $0 |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
BMEA
Biomea Fusion, Inc. |
$3.92 | $148.81 M | -1.17 | 107 | $0 |
CABA
Cabaletta Bio, Inc. |
$2.66 | $508.83 M | -6.16 | 154 | $0 |
CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
DYN
Dyne Therapeutics, Inc. |
$24.57 | $3.03 B | -7.77 | 191 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
EYPT
EyePoint Pharmaceuticals, Inc. |
$8.68 | $473.97 M | -5.03 | 165 | $43.27 M |
IMTX
Immatics N.V. |
$7.28 | $1.36 B | -12.3 | 572 | $54.00 M |
IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
VIRX
Viracta Therapeutics, Inc. |
$0.21 | $24.19 M | -0.5 | 26 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
